Journal article
Effect of tetrahydroaminoacridine on cognition, function and behaviour in Alzheimer's disease.
Abstract
OBJECTIVE: To determine the efficacy of tetrahydroaminoacridine (THA) in Alzheimer's disease.
DESIGN: Randomized, double-blind, multiple crossover trial with three treatment periods, each consisting of 3 weeks of active drug therapy and 3 weeks of placebo administration.
Authors
Molloy DW; Guyatt GH; Wilson DB; Duke R; Rees L; Singer J
Journal
Canadian Medical Association Journal, Vol. 144, No. 1, pp. 29–34
Publication Date
January 1, 1991
ISSN
0820-3946